The fine is for Pradaxa documents that have gone missing. The company is accused of hiding risk information about its blood thinner.
The FDA granted priority review for the experimental, all-oral Gaucher's disease treatment.
The $120.4-million deal is part of Savient's bankruptcy auction.
Vaccine LU AF20513 is the their third Alzheimer's collaboration.
A Penn State researcher thinks it can help women with menstrual cramps.
The HHS Secretary has some positive enrollment stats to share, but sentiment shows she and Obama need some reputation rehab.
The company expects to join the prescription weight-loss market by 2014's third quarter.
Pew Charitable Trust's proposed conflict of interest guidelines could mean even less face time for sales reps and less industry money for CME programs.
The Boston-based agency hopes the new department will allow teams a broader perspective.
Genentech has gone out of its way to keep doctors choosing Lucentis over cheaper Avastin, the paper reports, and they have little incentive to do otherwise.